Acute and chronic effects of dexfenfluramine on the porcine pulmonary artery

General Pharmacology

Volumn 30, Issue 3, 1998, Pages 403-410

  Desta, Bernabas ^a   Steed, Scott ^a   Ravel, Denis ^b   Laudignon, Nicole ^b   Vanhoutte, Paul M ^b   Boulanger, Chantal M ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

Author keywords

Endothelin 1; Endothelium; Nitric oxide; Norepinephrine; Platelets; Serotonin

Indexed keywords

ADENOSINE DIPHOSPHATE; DEXFENFLURAMINE; ENDOTHELIN 1; INDOMETACIN; LINSIDOMINE; METITEPINE; NITRIC OXIDE; NORADRENALIN; PROPRANOLOL; SEROTONIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL TONE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; GUINEA PIG; MALE; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; SWINE; THROMBOCYTE AGGREGATION; VASCULAR ENDOTHELIUM;

ANIMALS; FENFLURAMINE; MALE; MUSCLE, SMOOTH, VASCULAR; PULMONARY ARTERY; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; SWINE; VASOCONSTRICTION;

EID: 0032033871     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(97)00278-4     Document Type: Article

References (38)

1. Brenot F., Herve P., Petipretz P., Parent F., Duroux P., Simmonneau G. Primary pulmonary hypertension and fenfluramine use. Br. Heart J. 70:1993;537-541.
2. Buczko W., De Gaetano G., Garattini S. Effects of fenfluramine on 5-hydroxytryptamine uptake and release by rat blood platelets. Br J. Pharmac. 53:1975;563-568.
3. Caccia S., Conforti I., Duchier J., Garattini S. Pharmacokinetics of fenfluramine and norfenfluramine in volunteers given D- and DL-fenfluramine for 15 days. Eur. J. Clin. Pharmac. 29:1985;221-224.
4. Cohen R. A., Shepherd J. T., Vanhoutte P. M. Inhibitory role of the endothelium in the response of isolated coronary arteries to platelets. Science. 221:1983;273-274.
5. Flavahan N. A., Shimokawa H., Vanhoutte P. M. Pertussis toxin inhibits endothelium-dependent relaxations to certain agonists in porcine coronary arteries. J. Physiol. 408:1989;549-560.
6. Fuller R. W., Snoddy H. D., Robertson D. W. Mechanisms of effects of D-fenfluramine on brain serotonin metabolism in rats. uptake inhibition versus release Pharmac. Biochem. Behav. 30:1989;715-721.
7. Furchgott R. F., Vanhoutte P. M. Endothelium-derived relaxing and contracting factors. FASEB J. 3:1989;2007-2018.
8. Garattini S., Mennini T., Bendotti C., Invernizzi R., Samanin R. Neurochemical mechanism of action of drugs which modify feeding via the serotoninergic system. Appetite. 7(suppl.):1986;15-38.
9. Giaid A., Yanagisawa M., Langleben D., Michel R. P., Levy R., Shennib H., Kimura S., Masaki T., Duguid W. P., Stewart D. J. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N. Eng. J. Med. 328:1993;1732-1739.
10. 1C-like receptors. Naunyn-Schmiedeberg's Arch. Pharmac. 347:1993;471-477.
11. Goldie R. G., Paterson J. W., Wale J. L. Pharmacological responses of human and porcine lund parenchyma, bronchus and pulmonary artery. Br. J. Pharmac. 76:1982;515-521.
12. Golino P., Chiarello M. Serotonergic mechanisms in the regulation of the human coronary circulation in vivo. Endothelium. 1:1993;131-136.
13. Higenbottam T. Pathophysiology of pulmonary hypertension. Chest. 105(suppl.):1994;7-12.
14. Houston D. S., Shepherd J. T., Vanhoutte P. M. Adenine nucleotides, serotonin and endothelium-dependent relaxations to platelets. Am. J. Physiol. 58:1985;834-838.
15. Houston D. S., Shepherd J. T., Vanhoutte P. M. Aggregating human platelets cause direct contraction and endothelium-dependent relaxation of isolated canine coronary arteries. role of serotonin, thromboxane A2 and adenine nucleotides J. Clin. Invest. 78:1986;539-544.
16. Hoyer D., Clarke D. E., Fozard J. R., Hartig P. R., Martin G. R., Mylecharane E. J., Saxena P. R., Humphrey P. P. A. International Union of Pharmacology, Classification for 5-hydroxytryptamine (serotonin). Pharmac. Rev. 46:1994;157-203.
17. Lee S-L., Fanburg B. L. Beta adrenergic antagonists inhibit serotonin uptake by pulmonary vascular cells in culture. J. Pharmac. Exp. Ther. 257:1991;895-900.
18. Lüscher T. F. and Vanhoutte P. M. (1986) Endothelium-dependent responses to platelets and serotonin in spontaneously hypertensive rats. Hypertension 8(suppl. II), II-55-II-60.
19. Lüscher T. F., Rubanyi G. M., Aarhus L. L., Edoute Y., Vanhoutte P. M. Serotonin reduces coronary flow in the isolated heart of the spontaneously hypertensive rat. J. Hypert. 4R(suppl. 5):1986;S148-S150.
20. Lüscher T. F., Vanhoutte P. M. The Endothelium. Modulator of Cardiovascular Function:1990;CRC Press, Boca Raton, FL.
21. Martin F., Artigas F. Simultaneous effects of p-chloroamphetamine, D-fenfluramine, and reserpine on free and stored 5-hydroxytryptamine in brain and blood. J. Neurochem. 59:1992;1138-1144.
22. McTavish D., Heel R. C. Dexfenfluramine. a review of its pharmacological properties and therapeutic properties in obesity Drugs. 43(5):1992;713-733.
23. Moncada S., Palmer R. M., Higgs E. A. Nitric oxide. physiology, Pathophysiology and pharmacology Pharmac. Rev. 43:1991;109-142.
24. Moncada S. and Higgs E. A. (1993) The L-arginine-nitric oxide pathway (Edited by Epstein F. H.), pp. 2002-2012. Mechanisms of Disease, New Eng. J. Med.
25. Picotti G. B., Carruba M. O., Zambotti F., Mantegazza P. Effects of mazindol and D-fenfluramine on 5-hydroxytryptamine uptake, storage and metabolism in blood platelets. Eur. J. Pharmac. 42:1977;217-224.
26. Richards R. P., Gordon B. H., Ings R. M. J., Campbell D. B., King L. J. The measurement of d-fenfluramine and its metabolite, d-norfenfluramine in plasma and urine with an application of the method to pharmacokinetic studies. Xenobiotica. 19:1989;547-553.
27. Roubert P., Gillard V., Plas P., Guillon J-M., Chabrier P-E., Braquet P. Angiotensin II and phorbol-esters potently down-regulate endothelin (ET-) binding sites in vascular smooth muscle cells. Biochem. Biophys. Res. Comm. 164:1989;809-815.
28. Schaiberger P. H., Kennedy T. C., Miller F. C., Gal J., Petty T. L. Pulmonary hypertension associated with long-term inhalation of "crank" methamphetamine. Chest. 19:1993;547-553.
29. Schoeffter P., Hoyer D. 5-Hydroxytryptamine (5-HT)-induced endothelium-dependent relaxation of pig coronary arteries is mediated by 5-HT receptors similar to the 5-HT1D receptor subtype. J. Pharmacol. Exp. Ther. 252:1990;387-395.
30. Shimokawa H., Aarhus L. L., Vanhoutte P. M. Porcine coronary arteries with regenerated endothelium have a reduced endothelium-dependent responsiveness to aggregating platelets and serotonin. Circ. Res. 61:1987;256-270.
31. Shimokawa H., Vanhoutte P. M. Impaired endothelium-dependent relaxation to aggregating platelets and related vasoactive substances in porcine coronary arteries in hypercholesterolemia and atherosclerosis. Circ. Res. 64:1989;900-914.
32. Stewart D. J. Endothelin in cardiopulmonary disease. factor paracrine vs neurohumoral Eur. Heart J. 14(suppl.):1993;48-54.
33. Vane J. R. (1994) The Croonian lecture, 1993. The endothelium: maestro of the blood circulation. Phil. Trans R. Soc. Lond. B 348, 225-246.
34. Vanhoutte P. M. Serotonin and the Cardiovascular System. 1985;Raven Press, New York.
35. Vanhoutte P. M. Serotonin, hypertension and vascular disease. Netherlands J. Med. 38:1991;35-42.
36. Vanhoutte P. M., Boulanger C. M. Endothelium-dependent responses in hypertension. Hypert. Res. 18:1995;87-98.
37. Willerson J. T. Platelets, platelets mediators, and unstable coronary artery disease syndromes. Vanhoutte P. M., Saxena P. R., Paoletti R., Brunello N., Jackson A. S. Serotonin from Cell Biology to Pharmacology and Therapeutics. 1993;307-319 Kluwer, Dordrecht.
38. Zellers T. M., Shimokawa H., Yunginger J., Vanhoutte P. M. Heterogeneity of endothelium-dependent and endothelium-independent responses to aggregating platelets in porcine pulmonary arteries. Circ. Res. 68:1991;1437-1445.